Zanchetti Alberto, Grassi Guido, Mancia Giuseppe
Istituto Auxologico Italiano, Italy.
J Hypertens. 2009 May;27(5):923-34. doi: 10.1097/HJH.0b013e32832aa6b5.
The evidence for two recommendations of all major guidelines on hypertension is critically discussed. The first recommendation is that of initiating antihypertensive drug treatment when systolic blood pressure is at least 140 or diastolic blood pressure at least 90 mmHg in patients with grade 1 hypertension and low or moderate total cardiovascular risk, and even when blood pressure is in the high normal range in patients with diabetes and previous cardiovascular disease. The second recommendation is that of achieving systolic blood pressure levels below 140 mmHg in all hypertensive patients, including the elderly, and values below 130 mmHg in patients having diabetes and high/very-high-risk patients. Critical analyses of the results of available trials show that the evidence is scanty for both recommendations. Nonetheless, they can be accepted as prudent statements, as antihypertensive agents are very well tolerated and lowering systolic blood pressure below 130 mmHg appears well tolerated. However, wisdom should not be taken for evidence, and simple trials should be designed to look for more solid evidence in favour of current recommendations.
对所有主要高血压指南的两项建议的证据进行了批判性讨论。第一项建议是,对于1级高血压且心血管总体风险低或中等的患者,当收缩压至少为140 mmHg或舒张压至少为90 mmHg时开始抗高血压药物治疗;对于糖尿病患者和既往有心血管疾病的患者,即使血压处于高正常范围也应开始治疗。第二项建议是,所有高血压患者,包括老年人,收缩压应降至140 mmHg以下;糖尿病患者和高/极高风险患者,收缩压应降至130 mmHg以下。对现有试验结果的批判性分析表明,这两项建议的证据都不足。尽管如此,它们可被视为审慎的声明,因为抗高血压药物耐受性良好,将收缩压降至130 mmHg以下似乎耐受性也良好。然而,不应将经验视为证据,而应设计简单的试验以寻找更确凿的证据来支持当前的建议。